Next Gen Immuno-Oncology Congress 2018

  • 21-22 Jun 2018
  • Radisson Hotel Philadelphia Northeast, Trevose, PA, United States

Description

The Next Gen Immuno-Oncology Congress 2018 is dedicated to the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiome-derived immunotherapy.

The Next Gen Immuno-Oncology Congress 2018 covers topics such as:

  • Immune Checkpoint Inhibitors and Combinations (PD-1, PD-L1, PD-L4)
  • Neoantigens in personalized Cancer Immunotherapy
  • (Preclinical models for Immunecheckpoint modulators)
  • Preclinical and Translational Immuno-Oncology Developments
  • Biomarkers and Cancer Vaccines
  • Neoantigen Discovery by Next-Generation Sequencing
  • Microbiome in Cancer Immunotherapy (Targets and Challenges)
  • CAR-T cell therapy, Dendritic Cell Therapy
  • Tumor associated Macrophages as treatment in IO
  • Oncolytic viruses
  • Tumor microenvironment
  • Technologies for personalized TCR engineered cancer immunotherapies

The Next Gen Immuno-Oncology Congress 2018 brings together senior attendees with responsibilities in:

  • Cellular Therapy
  • Neoantigens and Microbiome
  • Immune Checkpoint Inhibitors

Past Events

Important

Please, check "Next Gen Immuno-Oncology Congress" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Oncology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions